“You Aren’t Going to Cut On Me!” Urgent Medical Decisions for Patients With Schizophrenia
Decision-making capacity assessments are a common part of psychiatric consultations,1 with a range of 4 –25% cited in the literature.2–5 The presence of a chronic psychotic disorder, such as schizophrenia, complicates these assessments.6–10 Depending on the phase of illness, severity, and treatment status, individuals with schizophrenia may have an elevated risk of impairments of decision-making capacity due to positive psychotic symptoms, poor insight, and cognitive dysfunction.6,7,11,12 Additionally, negative symptoms, including apathy and avolition, may impact capacity. (Source: Psychosomatics)
Source: Psychosomatics - January 19, 2018 Category: Psychiatry & Psychology Authors: Mina Boazak, Michael J. Peterson, William R. Smith, Zachary Hudson, Ann C. Schwartz Tags: Case Reports Source Type: research
“You aren′t going to cut on me!” Urgent Medical Decisions for Patients with Schizophrenia: How We Decided
Decision-making capacity of patients with schizophrenia remains a highly debated subject, both in terms of understanding the effects of the illness, and in the challenges presented by clinical scenarios. Clinicians are frequently asked to evaluate decision-making capacity in patients with schizophrenia admitted to medical/surgical services, and these cases pose many clinical and ethical challenges. (Source: Psychosomatics)
Source: Psychosomatics - January 19, 2018 Category: Psychiatry & Psychology Authors: Mina Boazak, Michael J. Peterson, William R. Smith V, Zachary Hudson, Ann C. Schwartz Source Type: research
Physical Symptom Burden and Its Association With Distress, Anxiety, and Depression in Breast Cancer
Physical symptom burden and psychologic symptoms are highly prevalent in women with breast cancer. The Distress Thermometer and Problem List (DT&PL) is commonly used in oncology clinics to screen for distress and its accompanying Physical Problem List (PPL) identifies pertinent physical symptoms. (Source: Psychosomatics)
Source: Psychosomatics - January 17, 2018 Category: Psychiatry & Psychology Authors: Daniel C. McFarland, Kelly M. Shaffer, Amy Tiersten, Jimmie Holland Tags: Original Research Report Source Type: research
Physical Symptom Burden and its Association with Distress, Anxiety and Depression in Breast Cancer
Physical symptom burden and psychological symptoms are highly prevalent in women with breast cancer. The Distress Thermometer and Problem List (DT&PL) is commonly used in oncology clinics to screen for distress and its accompanying Physical Problem List (PPL) identifies pertinent physical symptoms. However, the identification of physical symptoms found on the PPL has never been evaluated for its association with psychological symptoms in women with breast cancer. (Source: Psychosomatics)
Source: Psychosomatics - January 17, 2018 Category: Psychiatry & Psychology Authors: Daniel C. McFarland, Kelly M. Shaffer, Amy Tiersten, Jimmie Holland Source Type: research
Clinical Characteristics and Outcomes Associated With High-Dose Intravenous Thiamine Administration in Patients With Encephalopathy
Wernicke encephalopathy is a common neuropsychiatric syndrome due to thiamine deficiency. There is no consensus regarding thiamine dosing when Wernicke encephalopathy is suspected. A longstanding dosing strategy for Wernicke encephalopathy is 100mg daily, yet updated clinical guidelines suggest using high-dose intravenous (HDIV) thiamine. (Source: Psychosomatics)
Source: Psychosomatics - January 11, 2018 Category: Psychiatry & Psychology Authors: Zev M. Nakamura, Jason R. Tatreau, Donald L. Rosenstein, Eliza M. Park Tags: Original Research Report Source Type: research
Clinical Characteristics and Outcomes Associated with High Dose Intravenous Thiamine Administration in Patients with Encephalopathy
Wernicke ′s encephalopathy (WE) is a common neuropsychiatric syndrome due to thiamine deficiency. There is no consensus regarding thiamine dosing when WE is suspected. A longstanding dosing strategy for WE is 100mg daily, yet updated clinical guidelines suggest using high dose intravenous thiamine (HDIV) . (Source: Psychosomatics)
Source: Psychosomatics - January 11, 2018 Category: Psychiatry & Psychology Authors: Zev M. Nakamura, Jason R. Tatreau, Donald L. Rosenstein, Eliza M. Park Source Type: research
Substance Use Disorder Among Current Cancer Patients: Rates and Correlates Nationally in the Department of Veterans Affairs
Substance use disorders (SUDs) are known to cause or complicate treatment of many types of cancers. (Source: Psychosomatics)
Source: Psychosomatics - January 10, 2018 Category: Psychiatry & Psychology Authors: Pochu Ho, Robert Rosenheck Tags: Original Research Report Source Type: research
Substance Use Disorder Among Current Cancer Patients: Rates and Correlates Nationally in the Department of Veterans Affairs
Substance use disorders (SUD) are known to cause or complicate treatment of many types of cancers but rates of current SUD among patients currently in treatment for cancer and their correlates have not been studied systematically. (Source: Psychosomatics)
Source: Psychosomatics - January 10, 2018 Category: Psychiatry & Psychology Authors: Pochu Ho, Robert Rosenheck Source Type: research
Jimmie C. Holland, M.D.
Jimmie C. Holland, MD, internationally recognized as the founder of the field of Psycho-Oncology, died suddenly on December 24, 2017, at the age of 89. Dr. Holland, who was affectionately known by her first name “Jimmie,” had a profound global influence on the fields of Psycho-Oncology and Psychosomatic Medicine. Dr. Holland was the Attending Psychiatrist and Wayne E. Chapman Chair at Memorial Sloan Kettering (MSK) Cancer Center and Professor of Psychiatry, Weill Medical College of Cornell University in New York. (Source: Psychosomatics)
Source: Psychosomatics - January 9, 2018 Category: Psychiatry & Psychology Authors: William Breitbart Tags: Memorial Minute Source Type: research
Memorial Minute: Jimmie C. Holland, MD
Jimmie C Holland, MD, internationally recognized as the founder of the field of Psycho-oncology, died suddenly on December 24, 2017, at the age of 89. Dr. Holland, who was affectionately known by her first name “Jimmie”, had a profound global influence on the fields of Psycho-oncology and Psychosomatic Medicine. Dr. Holland was the Attending Psychiatrist and Wayne E. Chapman Chair at Memorial Sloan-Kettering Cancer Center and Professor of Psychiatry, Weill Medical College of Cornell University in New Y ork. (Source: Psychosomatics)
Source: Psychosomatics - January 9, 2018 Category: Psychiatry & Psychology Authors: William Breitbart Source Type: research
The Inpatient Assessment and Management of Motor Functional Neurological Disorders: An Interdisciplinary Perspective
Motor functional neurologic disorders (FND) —previously termed “hysteria” and later “conversion disorder”—are exceedingly common and frequently encountered in the acute hospital setting. Despite their high prevalence, patients with motor FND can be challenging to diagnose accurately and manage effectively. To date, there is limite d guidance on the inpatient approach to the neuropsychiatric evaluation of patients with functional (psychogenic) neurologic symptoms. (Source: Psychosomatics)
Source: Psychosomatics - January 8, 2018 Category: Psychiatry & Psychology Authors: Kathleen McKee, Sean Glass, Caitlin Adams, Christopher D. Stephen, Franklin King, Kristin Parlman, David L. Perez, Nicholas Kontos Tags: Perspective Source Type: research
